Lumonus’ Post

On 14 June 2024, our industry symposium entitled "Quality-assured hyperthermia and flash radiotherapy" took place as part of the 30th Congress of the German Society for Radiation Oncology (DEGRO). Prof. Dr. Udo Gaipl (Head of Translational Radiobiology, Radiation Immunobiology, Department of Radiation Oncology, University Hospital Erlangen) and PD Dr. med. habil. Gunther Klautke (Congress President DEGRO, Director of the Clinic of Radiation Oncology, Chemnitz Hospital) assumed the role of chairmen.   The lecture "Do the immunological effects of hyperthermia and FLASH radiotherapy go together?" by Prof. Dr. Udo Gaipl is now available for download as a PDF. #flash #hyperthermia #DEGRO #oncology #radiotherapy #hyperthermie #strahlentherapie

While at #ASTRO24, Vaseem Khatri, MD shared insight from a multi-institutional report of trastuzumab-deruxtecan and stereotactic radiosurgery for HER2+ #BreastCancer brain metastases. Learn more ➡️ https://lnkd.in/eP8s-_tA American Society for Radiation Oncology (ASTRO) #MoffittASTRO24

We are excited to share that Advances in Radiation Oncology has published our research from the BREAST-ART trial. In this article, we demonstrated feasibility, challenges, and practical solutions for the use of online adaptive radiotherapy in whole breast irradiation. Special thanks to all of the co-authors who contributed to this this work: Desirée van den Bongard (PI); Wilko Verbakel Judith Middelburg- van Rijn Barbara Rijksen Marjan Admiraal Jorrit Visser Jessica van der Himst Ewa Bucko Ben Slotman Angelique van Vlaenderen and the BREAST-ART study group

Arnold Pompos, Ph.D., Associate Professor, was invited to give a colloquium lecture in the #physics department at The University of Texas at Arlington this week. His talk was titled, "Precision Radiation Oncology: Navigating the Challenges of Ultra-Personalized Cancer Therapy." #radiotherapy #cancertreatment #radiationoncology #cancer #cancerresearch #medphys #physicists

Steven Montalvo, M.D., PGY-4 #medicalresident, was recently a guest on At The Beam, a medical education podcast that is focused on #radiationoncology. Listen to Dr. Montalvo speak about the workup and management of #medulloblastoma. https://lnkd.in/dwpyYhti #radiotherapy #cancertreatment #oncology #radiationtherapy  #radiationoncology #cancercare #cancertreatment #braintumor #braincancer #cnscancer

Can MRI-guided Radiation Treatment be a Game Changer in Cancer Management ? Join Dr. Behjet Mirza, Fellow (FHPRO), Department of Radiation Oncology, MVRCCRI, in an insightful conversation with Dr. Swarupa Mitra, Director and Head, Radiation Oncology, Fortis Memorial Research Institute, Gurgaon. They explore the evolution of radiation therapy techniques—from Cobalt machines to 3D Conformal therapy and IMRT/VMAT, and now to the cutting-edge MRI-guided LINAC. Discover how these advancements are transforming patient care, improving outcomes, and shaping the future of Radiation Oncology. #CancerManagement #RadiationTherapy #MRIGuidedLINAC #OncologyCare #CancerTreatment #RadiationOncology #MedicalInnovation #FutureOfCancerCare #CancerAwareness

At #ASTRO24, Matthew Adams shares insight into #RadOnc provider perceptions and attitudes towards virtual tumor boards. The study assesses whether quality was maintained and if work-life balance improved. Learn more ➡️ https://lnkd.in/eA3pdRhu American Society for Radiation Oncology (ASTRO) #MoffittASTRO24

AGITG TOPGEAR findings: First randomised evidence of preoperative chemoradiotherapy for gastric cancer announced. “Key findings: The trial evaluated the addition of chemoradiotherapy before surgery to standard care which involved giving chemotherapy both before and after surgery in 574 patients with cancer of the stomach or oesophagus/stomach junction. Patients receiving chemoradiotherapy were found to have higher rates of complete response of their tumour at the time of surgery, compared with standard care (17% versus 8%). However there was no significant benefit of chemoradiotherapy on long term survival which was the main aim of the trial. The survival rate at 5 years was about 45% in both groups. As a result, it is recommended that chemoradiotherapy not become a routine standard of care.” September 14, 2024 Professor Leong says, “Thank you to everyone involved in AGITG TOPGEAR for their tireless efforts over the duration of this large, academic trial. This trial involved hundreds of people around the world and delivering these findings is a significant achievement that we all should be proud of.” Source: https://lnkd.in/gBPtpjrF Trevor Leong Trans Tasman Radiation Oncology Group (TROG Cancer Research) GI Cancer Institute & Australasian Gastro-Intestinal Trials Group

Does radiography pose a cancer risk due to radiation exposure? Today, on World Radiography Day, Dr Sasindran P R, Senior Consultant in Radiation Oncology at American Oncology Institute, Calicut, addresses this important concern. Watch this video to understand how to stay informed and protected during diagnostic procedures. #WorldRadiographyDay #RadiationOncology #Radiography #RadiationExposure #AmericanOncologyInstitute #AOICancerCare #WeJourneyWithYou

Arash Naghavi, MD, joins Peter Johnstone, MD, at #ASTRO24 to discuss a novel trial offering personalized medicine to treat #sarcoma. The study utilized genomics to decide the dose and radiomics to determine what portion of the tumor is most resistant and should be targeted. Learn more ➡️ https://lnkd.in/eNSMqgZH American Society for Radiation Oncology (ASTRO) #MoffittASTRO24